In June 13th, Gelunhui announced that the board of directors of Innovative Phar (00399.HK) will convene on Friday, June 28, 2024 to consider and approve (among other things) the annual consolidated results of the company and its subsidiaries for the full year ending March 31, 2024.
领航医药生物科技(00399.HK)将于6月28日举行董事会会议以审批年度业绩
Innovative Phar (00399.HK) will hold a board of directors meeting on June 28 to approve annual performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.